Zimmer Biomet Holdings Return on Tangible Equity 2010-2025 | ZBH
Current and historical return on tangible equity values for Zimmer Biomet Holdings (ZBH) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Zimmer Biomet Holdings Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $0.91B | $-1.05B | -89.11% |
| 2024-12-31 | $0.90B | $-1.07B | -91.08% |
| 2024-09-30 | $1.08B | $-1.19B | -106.07% |
| 2024-06-30 | $1.00B | $-0.78B | -100.35% |
| 2024-03-31 | $0.96B | $-0.92B | -84.12% |
| 2023-12-31 | $1.03B | $-1.19B | -77.17% |
| 2023-09-30 | $0.48B | $-1.08B | -33.15% |
| 2023-06-30 | $0.51B | $-1.39B | -31.97% |
| 2023-03-31 | $0.45B | $-1.65B | -25.78% |
| 2022-12-31 | $0.23B | $-1.62B | -12.18% |
| 2022-09-30 | $0.28B | $-1.68B | -14.23% |
| 2022-06-30 | $0.23B | $-2.05B | -10.10% |
| 2022-03-31 | $0.22B | $-2.27B | -8.40% |
| 2021-12-31 | $0.40B | $-1.79B | -13.81% |
| 2021-09-30 | $0.82B | $-2.97B | -23.49% |
| 2021-06-30 | $0.92B | $-3.31B | -24.45% |
| 2021-03-31 | $0.57B | $-3.59B | -14.23% |
| 2020-12-31 | $-0.14B | $-4.12B | 3.36% |
| 2020-09-30 | $-0.15B | $-4.01B | 3.60% |
| 2020-06-30 | $0.04B | $-4.28B | -0.81% |
| 2020-03-31 | $0.38B | $-4.15B | -7.99% |
| 2019-12-31 | $1.13B | $-4.47B | -22.34% |
| 2019-09-30 | $-0.09B | $-4.80B | 1.65% |
| 2019-06-30 | $-0.36B | $-5.46B | 6.19% |
| 2019-03-31 | $-0.31B | $-5.55B | 5.07% |
| 2018-12-31 | $-0.38B | $-6.00B | 5.90% |
| 2018-09-30 | $1.75B | $-6.20B | -25.97% |
| 2018-06-30 | $1.69B | $-6.55B | -22.75% |
| 2018-03-31 | $1.69B | $-6.97B | -20.92% |
| 2017-12-31 | $1.81B | $-7.29B | -20.88% |
| 2017-09-30 | $0.65B | $-8.92B | -7.01% |
| 2017-06-30 | $0.71B | $-9.13B | -7.43% |
| 2017-03-31 | $0.50B | $-9.40B | -5.23% |
| 2016-12-31 | $0.31B | $-9.76B | -3.27% |
| 2016-09-30 | $0.36B | $-10.03B | -3.98% |
| 2016-06-30 | $0.23B | $-8.81B | -2.67% |
| 2016-03-31 | $0.08B | $-8.96B | -1.02% |
| 2015-12-31 | $0.15B | $-8.79B | -2.88% |
| 2015-09-30 | $0.17B | $-7.51B | -8.36% |
| 2015-06-30 | $0.32B | $-7.55B | 44.55% |
| 2015-03-31 | $0.67B | $3.59B | 19.70% |
| 2014-12-31 | $0.72B | $3.43B | 22.25% |
| 2014-09-30 | $0.83B | $3.39B | 26.45% |
| 2014-06-30 | $0.81B | $3.20B | 27.06% |
| 2014-03-31 | $0.78B | $2.94B | 27.62% |
| 2013-12-31 | $0.78B | $2.98B | 28.75% |
| 2013-09-30 | $0.68B | $2.82B | 26.01% |
| 2013-06-30 | $0.70B | $2.59B | 28.01% |
| 2013-03-31 | $0.77B | $2.46B | 31.36% |
| 2012-12-31 | $0.76B | $2.55B | 31.76% |
| 2012-09-30 | $0.76B | $2.42B | 33.57% |
| 2012-06-30 | $0.77B | $2.33B | 35.12% |
| 2012-03-31 | $0.76B | $2.22B | 33.91% |
| 2011-12-31 | $0.76B | $2.09B | 33.36% |
| 2011-09-30 | $0.64B | $2.18B | 27.21% |
| 2011-06-30 | $0.64B | $2.51B | 26.91% |
| 2011-03-31 | $0.60B | $2.36B | 25.94% |
| 2010-12-31 | $0.60B | $2.36B | 26.31% |
| 2010-09-30 | $0.72B | $2.27B | 32.92% |
| 2010-06-30 | $0.68B | $2.28B | 31.21% |
| 2010-03-31 | $0.72B | $2.17B | 33.87% |
| 2009-12-31 | $0.72B | $2.00B | 34.64% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $18.026B | $7.679B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.390B | 27.94 |
| Boston Scientific (BSX) | United States | $154.114B | 38.58 |
| Stryker (SYK) | United States | $145.370B | 30.40 |
| EssilorLuxottica (ESLOY) | France | $128.999B | 0.00 |
| Medtronic (MDT) | Ireland | $107.400B | 15.23 |
| Haleon (HLN) | United Kingdom | $51.375B | 29.26 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.537B | 0.00 |
| ResMed (RMD) | United States | $35.781B | 26.88 |
| GE HealthCare Technologies (GEHC) | United States | $32.121B | 15.25 |
| Agilent Technologies (A) | United States | $31.661B | 20.57 |
| Terumo (TRUMY) | Japan | $27.316B | 35.48 |
| Insulet (PODD) | United States | $22.872B | 89.78 |
| Koninklijke Philips (PHG) | Netherlands | $21.440B | 15.41 |
| Baxter (BAX) | United States | $15.164B | 11.32 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.767B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $5.893B | 20.51 |
| Lantheus Holdings (LNTH) | United States | $5.336B | 13.46 |
| Prestige Consumer Healthcare (PBH) | United States | $4.224B | 18.87 |
| Perrigo (PRGO) | Ireland | $3.672B | 9.31 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.304B | 15.05 |
| ICU Medical (ICUI) | United States | $3.213B | 23.69 |
| Envista Holdings (NVST) | United States | $3.068B | 25.49 |
| GN Store Nord (GNNDY) | Denmark | $2.170B | 17.98 |
| QuidelOrtho (QDEL) | United States | $2.005B | 13.79 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 40.61 |
| AtriCure (ATRC) | United States | $1.683B | 0.00 |
| Acuren (TIC) | United States | $1.297B | 0.00 |
| Neogen (NEOG) | United States | $1.235B | 15.81 |
| AdaptHealth (AHCO) | United States | $1.181B | 11.99 |
| Green Thumb Industries (GTBIF) | United States | $1.143B | 25.71 |
| Kestra Medical Technologies (KMTS) | United States | $1.062B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 12.74 |
| BioLife Solutions (BLFS) | United States | $0.983B | 0.00 |
| InMode (INMD) | Israel | $0.907B | 9.14 |
| Evolus (EOLS) | United States | $0.643B | 0.00 |
| CeriBell (CBLL) | United States | $0.621B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.549B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.536B | 0.00 |
| Owens & Minor (OMI) | United States | $0.491B | 4.07 |
| Capricor Therapeutics (CAPR) | United States | $0.466B | 0.00 |
| Surmodics (SRDX) | United States | $0.421B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.410B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.61 |
| Aurora Cannabis (ACB) | Canada | $0.293B | 52.10 |
| Cresco Labs (CRLBF) | United States | $0.289B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.259B | 21.87 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| ZimVie (ZIMV) | United States | $0.251B | 11.40 |
| Verano Holdings (VRNOF) | United States | $0.226B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.224B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.222B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.213B | 0.00 |
| Quanterix (QTRX) | United States | $0.204B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.197B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.45 |
| Brainsway (BWAY) | Israel | $0.193B | 51.10 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Omeros (OMER) | United States | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.48 |
| Organigram Global (OGI) | Canada | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.152B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.139B | 17.12 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| MacroGenics (MGNX) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Agape ATP (ATPC) | $0.080B | 0.00 | |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.061B | 0.00 |
| Zynex (ZYXI) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| United Health Products (UEEC) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.29 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.033B | 44.71 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |